Clinical Trial Update: Topical rhThrombin as an Adjunct to Hemostasis During Segmental Hepatectomy [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for topical rhThrombin as an adjunct to hemostasis during segmental hepatectomy (Phase 1/Phase 2) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatectomy

Drugs mentioned

• topical rhThrombin (rhThrombin)

Snippet

Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Conditions: Hepatectomy | Phase 1, Phase 2 | Status: COMPLETED